Restriction Factors Against Recombinant Adeno-associated Virus Vectormediated Gene Transfer in Dystrophin-deficient Muscles

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|16|3|168-183

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.16, Iss.3, 2016-06, pp. : 168-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)

By  

Current Gene Therapy, Vol. 15, Iss. 4, 2015-01 ,pp. : 395-415

Bentham Science Publishers

Access to resources Recommend Favorite

Immunogenic Issues Concerning Recombinant Adeno-Associated Virus Vectors for Gene Therapy

By  

Current Gene Therapy, Vol. 2, Iss. 4, 2002-01 ,pp. : 485-500

Bentham Science Publishers

Access to resources Recommend Favorite

Biosafety of Recombinant Adeno-associated Virus Vectors

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-01 ,pp. : 434-452

Bentham Science Publishers

Access to resources Recommend Favorite

Prevalence of Neutralizing Factors Against Adeno-Associated Virus Types 2 in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

By  

Current Gene Therapy, Vol. 13, Iss. 3, 2013-06 ,pp. : 182-188

Bentham Science Publishers

Access to resources Recommend Favorite

Adeno-Associated Virus-Mediated Gene Transfer in Hematopoietic Stem/Progenitor Cells as a Therapeutic Tool

By  

Current Gene Therapy, Vol. 6, Iss. 6, 2006-12 ,pp. : 683-698

Bentham Science Publishers

Access to resources Recommend Favorite